Skip to main content
. Author manuscript; available in PMC: 2009 Jul 1.
Published in final edited form as: Antiviral Res. 2008 Feb 25;79(1):71–79. doi: 10.1016/j.antiviral.2008.01.157

Figure 5.

Figure 5

Effect of cationic liposome-DNA complexes (CLDC) on serum amylase. Treatment schedule and mice were the same as in Figure 2. The chemistry panel included albumin, alkaline phosphatase, alanine transferase, amylase, total bilirumin, blood-urea-nitrogen, calcium, phosphorous, creatinine, sodium, potassium, total protein, globulin, and glucose. Only amylase was possibly affected by CLDC treatment. (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 compared to placebo using one-way analysis of variance with a Newman-Keuls Multiple Comparison test).